IMMUNMODULATORISCHE VORLÄUFERZELLE
European patent · EP2984163 · In force
Register entry
- Publication number
- EP2984163
- Application number
- EP15729886
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 9, 2015
- Published
- Feb 17, 2016
- Granted
- Feb 1, 2017
- Protection ends at the latest
- Jun 8, 2035
- Next annual fee due
- Jun 30, 2027
- IPC classes
- C12N 5/071 (2010.01)C12N 5/078 (2010.01)
- Priority
- GB 201410504 12.06.2014
- PCT application
- PCT/GB2015/051673 09.06.2015
- PCT publication
- WO2015/189587 17.12.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Jul 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 01.07.2025
- Jul 1, 2024
Change
Published in Swissreg on 01.07.2024
- Apr 3, 2024
Agent removed
- Owner
- Cell Therapy Limited, Institute of Life Sciences, First Floor, Room 137, School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom (removed)
- Representative
- VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern (removed)
- Inventor
- REGINALD, Ajan, Cell Therapy Limited, Institute of Life Sciences, First Floor Room 137, School of Medicine, Swansea University, Singleton Park, Swansea, West Glamorgan SA2 8PP, United Kingdom, EVANS, Martin John, Cell Therapy Limited, Institute of Life Sciences, First Floor Room 137, School of Medicine, Swansea University, Singleton Park, Swansea, West Glamorgan SA2 8PP, United Kingdom, SULTAN, Sabena, Cell Therapy Limited, Institute of Life Sciences, First Floor Room 137, School of Medicine, Swansea University, Singleton Park, Swansea, West Glamorgan SA2 8PP, United Kingdom (removed)
- Register addresses
Published in Swissreg on 03.04.2024
- Apr 3, 2024
Agent entered
- Register addresses
- Owner
- Cell Therapy Limited, Institute of Life Sciences, First Floor, Room 137, School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
- Inventor
- REGINALD, Ajan, Cell Therapy Limited, Institute of Life Sciences, First Floor Room 137, School of Medicine, Swansea University, Singleton Park, Swansea, West Glamorgan SA2 8PP, United Kingdom, EVANS, Martin John, Cell Therapy Limited, Institute of Life Sciences, First Floor Room 137, School of Medicine, Swansea University, Singleton Park, Swansea, West Glamorgan SA2 8PP, United Kingdom, SULTAN, Sabena, Cell Therapy Limited, Institute of Life Sciences, First Floor Room 137, School of Medicine, Swansea University, Singleton Park, Swansea, West Glamorgan SA2 8PP, United Kingdom
Published in Swissreg on 03.04.2024
- Jul 1, 2023
Change
Published in Swissreg on 01.07.2023
- Jul 1, 2022
Change
Published in Swissreg on 01.07.2022
- Mar 30, 2017
Agent entered
- Representative
- VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern
Published in Swissreg on 30.03.2017
1 earlier entry
- Feb 1, 2017
Granted
Published in Swissreg on 01.02.2017
Parties
Inventor
Swansea West Glamorgan SA2 8PP, GB
Swansea West Glamorgan SA2 8PP, GB
Swansea West Glamorgan SA2 8PP, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.